Your session is about to expire
← Back to Search
Virtual Reality Therapy for Chemotherapy Discomfort
N/A
Waitlist Available
Led By Cody Stansel, MSN
Research Sponsored by Cody Stansel
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Not currently experiencing any contagious conditions, infections, or diseases (particularly of the eyes, skin, or scalp)
No previous history of seizures, losses of awareness, or other symptoms linked to an epileptic condition
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 12 months
Awards & highlights
Study Summary
This trial will test whether virtual reality can help distract patients from the discomfort of chemotherapy and improve their experience.
Who is the study for?
This trial is for English-speaking adults over 18 with cancer, who are getting chemotherapy but don't have devices like pacemakers, aren't prone to motion sickness or seizures, and aren't taking certain heart medications. They shouldn't be contagious or have eye, skin, scalp infections.Check my eligibility
What is being tested?
The study tests if virtual reality can help distract patients from pain and stress during chemo sessions in the infusion clinic. It includes wearing VR gear while undergoing treatment and monitoring heart rate changes and any signs of cyber sickness.See study design
What are the potential side effects?
While not drug-related, side effects may include discomfort from wearing VR equipment or feelings of nausea due to motion sensitivity (cyber sickness), especially for those who might be sensitive to immersive environments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I do not have any contagious illnesses right now.
Select...
I have never had seizures or unexplained losses of awareness.
Select...
I am not currently undergoing treatment with radioactive drugs.
Select...
I am not on medication for irregular heartbeats.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ approximately 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Measure the affect of Virtual Reality Therapy on improving pain
Measure the affect of Virtual Reality Therapy on improving stress
Positive or negative effect of Virtual Reality therapy on improving the experience of participants receiving chemotherapy
Secondary outcome measures
Rate of cyber sickness (Virtual Reality Therapy Arm Only)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Virtual Reality TherapyExperimental Treatment4 Interventions
Participants will watch videos for 11 minutes that will allow them to view nature, dinosaurs, animals, and human interactions in three dimension.
Group II: Control GroupActive Control2 Interventions
This group will not watch videos, but will continue with their normal routine as if nothing has changed.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Questionnaires
2013
Completed Phase 2
~3330
Find a Location
Who is running the clinical trial?
Cody StanselLead Sponsor
Cody Stansel, MSNPrincipal InvestigatorVanderbilt-Ingram Cancer Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have never had seizures or unexplained losses of awareness.I am not currently undergoing treatment with radioactive drugs.I have been diagnosed with cancer.I speak English.I have appointments long enough to complete virtual reality treatment and agree to participate on the day.I am not on medication for irregular heartbeats.I do not have any contagious illnesses right now.You do not have a device that helps regulate your heart rate or rhythm, such as a pacemaker.I am 18 years old or older.You do not get motion sickness easily.
Research Study Groups:
This trial has the following groups:- Group 1: Control Group
- Group 2: Virtual Reality Therapy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are being included in the scope of this clinical research?
"Affirmative. Clinicaltrials.gov confirms that this clinical trial, initially posted on November 1st 2021, is presently seeking out patients to enrol in the study. The research requires 100 participants from a single medical centre."
Answered by AI
Share this study with friends
Copy Link
Messenger